Discover 1,668 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,668
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
for
Colitis, Ulcerative
Location: Chapel Hill NC, Richmond VA, Summerville SC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07577856
Phase 3, Recruiting
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
for
Acute Myeloid Leukemia With FLT3/ITD Mutation,
Location: Chapel Hill NC, Philadelphia PA, Columbus OH,
Sponsor: Uma Borate
Sex: All
Age: 18+
Code: NCT06222580
Phase 1, Recruiting
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
Location: Greensboro NC, Charlotte NC, Charlottesville VA,
Sponsor: UroGen Pharma Ltd.
Sex: All
Age: 18+
Code: NCT06774131
Phase 3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Chapel Hill NC, Winston-Salem NC, Charlotte NC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase 2, Recruiting
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
for
Surgery, Pain, Postoperative
Location: Chapel Hill NC, Camden NJ, Philadelphia PA, Detroit MI,
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT05722002
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Chapel Hill NC, Fairfax VA, Washington D.C. DC,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase 2, Recruiting
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
for
Pancreatic Ductal Adenocarcinoma
Location: Chapel Hill NC, Philadelphia PA, New York NY,
Sponsor: Gulam Manji
Sex: All
Age: 18+
Code: NCT06048484
Phase 2, Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Chapel Hill NC, Richmond VA, Pittsburgh PA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
for
Oncology, Myeloid Leukemia, Acute, Cancer
Location: Chapel Hill NC, Winston-Salem NC, Birmingham AL,
Sponsor: University of Rochester
Sex: All
Age: 60+
Code: NCT06697600
Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Location: Chapel Hill NC, Columbus OH, New York NY, Boston MA,
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT06465953
Phase 3, Recruiting
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
for
Urothelial Cancer, Bladder Cancer
Location: Chapel Hill NC, Norfolk VA, Nashville TN,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07129993
Phase 2, Phase 3, Recruiting
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
for
Alopecia Areata
Location: Chapel Hill NC, Charlotte NC, Plymouth Meeting PA,